BioHealth News
Maryland Global Consulting Program – Unlocking Your Business’s Global Potential
Ready to take your business to the global stage? Join the Maryland Global Consulting Program through the Robert H. Smith School of Business Center…
Read More
BioHealth Capital Region Retains #3 Spot in GEN’s Top U.S. Biopharma Clusters for 2024
The BioHealth Capital Region (Maryland, Virginia, and Washington, D.C.) has successfully retained its position as the #3 biopharma cluster in the U.S. for 2024.…
Read More
MedCityNews: How Startup miRecule Leveraged Its RNA Platform Tech to Land a Sanofi Alliance
RNA therapies developer miRecule is partnered with Sanofi on the development of a treatment for facioscapulohumeral muscular dystrophy, or FSHD. MiRecule, winner in the…
Read More
Mirecule Wins MedCity INVEST 2024 Competition
Chicago, May 2024 — miRecule, a cutting-edge startup focused on developing antibody RNA conjugate therapeutics, clinched the top spot at the prestigious MedCity INVEST…
Read More
Adventist HealthCare Names BHI Board Member John Sackett President and CEO
Gaithersburg, Md. – Adventist HealthCare has named John Sackett as its next president and CEO, effective Aug. 4, 2024. Sackett has served as Adventist HealthCare’s chief operating…
Read More
TEDCO Announces SSBCI Investment in Solaxa Inc.
Maryland-based biopharmaceutical company receives funding from TEDCO’s Venture Funds' COLUMBIA, Md., (July 23, 2024) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $500,000…
Read More
Embracing Home as a Health Care Hub: FDA’s Virtual Stakeholder Listening Session
On July 25, 2024, the FDA will host a significant virtual public meeting, "Home as a Health Care Hub – Stakeholder Listening Session," from…
Read More
Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
GERMANTOWN, Md., July 23, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of…
Read More
Emmes Group partners with Miimansa AI to accelerate adoption of Generative AI in clinical research
ROCKVILLE, Md., July 23, 2024 /PRNewswire/ -- Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), today announced a multi-year strategic partnership…
Read More
WBJ: JLL experts explore the future and changes of life sciences real estate in D.C.
In the rapidly evolving world of life sciences, the real estate sector is experiencing significant shifts and opportunities. JLL’s latest report, U.S. Life Sciences Property…
Read More
Children’s National Innovational District: Closing the ‘Valley of Death’: Pioneering – and paying for – new therapies
With the advent of life-changing cell and gene therapies (CGTs) to treat pediatric diseases, price is becoming a significant obstacle to care and cures.…
Read More
FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients
By: Patrizia Cavazzoni, MD, Director, Center for Drug Evaluation and Research and Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research An…
Read More
Discover Innovation at the 2024 NCI Technology Showcase
The National Cancer Institute's (NCI) Technology Transfer Center invites you to the 2024 Technology Showcase on September 4th, at the Frederick National Laboratory Advanced…
Read More
Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing
BioMaP-Consortium Project Agreement Will Combine Sustainable Biochemical Production with AI To Demonstrate a Scalable Platform for the Quick Manufacture of Pharmaceutical Ingredients. STERLING, Va.,…
Read More
Life Sciences Real Estate and Talent Trends: Insights from Matt Gardner, Head of Life Sciences, Americas, CBRE on BioTalk
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Matt Gardner, Head of Life Sciences, Americas, at…
Read More